Tommaso Francesco Aiello
Overview
Explore the profile of Tommaso Francesco Aiello including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
25
Citations
41
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
COVID-19 Patients Benefitting From Remdesivir for Improved Survival: A Neural Network-Based Approach
Garcia-Vidal C, Teijon-Lumbreras C, Aiello T, Chumbita M, Menendez R, Subira A, et al.
J Med Virol
. 2025 Mar;
97(3):e70276.
PMID: 40059457
Conflicting results from randomized trials regarding the efficacy of remdesivir for COVID-19 have been reported. We aimed to develop a neural network (NN) to identify COVID-19 patients who would derive...
2.
Chumbita M, Peyrony O, Teijon-Lumbreras C, Monzo-Gallo P, Aiello T, Gallardo-Pizarro A, et al.
Int J Infect Dis
. 2025 Mar;
153:107848.
PMID: 40043678
No abstract available.
3.
Marco D, Brey M, Anguera S, Pitart C, Grafia I, Bodro M, et al.
Crit Care
. 2025 Feb;
29(1):63.
PMID: 39910660
Background: Time to positivity (TTP) and differential TTP (DTP) emerge as diagnostic and prognostic tools for bloodstream infections (BSI) though specific cut-off values need to be determined for each pathogen....
4.
Vines J, Herrera S, Vergara A, Roca I, Vila J, Aiello T, et al.
Microbiol Spectr
. 2025 Jan;
13(3):e0192824.
PMID: 39873515
Importance: Carbapenem-resistant poses a significant challenge due to its broad antibiotic resistance. Cefiderocol is a novel antibiotic aimed at combating infections caused by such organisms. However, if these pathogens develop...
5.
Gallardo-Pizarro A, Teijon-Lumbreras C, Monzo-Gallo P, Aiello T, Chumbita M, Peyrony O, et al.
Antibiotics (Basel)
. 2025 Jan;
14(1).
PMID: 39858299
The rise of multidrug-resistant (MDR) infections demands personalized antibiotic strategies for febrile neutropenia (FN) in hematological malignancies. This study investigates machine learning (ML) for identifying patient profiles with increased susceptibility...
6.
Salmanton-Garcia J, Marchesi F, Navratil M, Piukovics K, Del Principe M, Criscuolo M, et al.
Am J Hematol
. 2024 Dec;
100(3):358-374.
PMID: 39715069
Community-acquired respiratory viral infections (CARV) significantly impact patients with hematological malignancies (HM), leading to high morbidity and mortality. However, large-scale, real-world data on CARV in these patients is limited. This...
7.
Lopera C, Monzo P, Aiello T, Chumbita M, Peyrony O, Gallardo-Pizarro A, et al.
Microbiol Spectr
. 2024 Aug;
12(10):e0296123.
PMID: 39194256
Importance: Multidrug-resistant (MDR) bacteria pose a global public health threat as they are more challenging to treat, and they are on the rise. Solid cancer patients are often immunocompromised due...
8.
Peyrony O, Garcia-Pouton N, Chumbita M, Teijon-Lumbreras C, Aiello T, Monzo-Gallo P, et al.
Open Forum Infect Dis
. 2024 Jul;
11(7):ofae398.
PMID: 39070045
Background: This study aimed to describe documented infections associated with postinfusion fever after CAR T-cell therapy and to evaluate daily changes in vital signs, laboratory results, and the National Early...
9.
Monzo-Gallo P, Lopera C, Badia-Tejero A, Machado M, Garcia-Rodriguez J, Vidal-Cortes P, et al.
Int J Infect Dis
. 2024 Jul;
146:107188.
PMID: 39067149
No abstract available.
10.
Pinana J, Vazquez L, Heras I, Aiello T, Lopez-Corral L, Arroyo I, et al.
Front Oncol
. 2024 Jul;
14:1389345.
PMID: 39015498
Introduction: Scarce real-life data exists for COVID-19 management in hematologic disease (HD) patients in the Omicron era. Purpose: To assess the current clinical management and outcome of SARS-CoV-2 infection diagnosed,...